Review
Cutaneous adverse reactions to lenalidomide
a Department of Clinical and Experimental Medicine, School and Unit of Allergy and Clinical Immunology, University of Messina, Italy
b Division of Hematology, University of Messina, Italy
c Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, Italy
d Institute of Biomedicine and Molecular Immunology “A. Monroy” (IBIM) – Consiglio Nazionale delle Ricerche (CNR), Palermo, Italy
Read
9855
Timeswas read the article
3205
Total PDF
6650
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 59 | 21 | 80 |
| 2025 11 | 263 | 142 | 405 |
| 2025 10 | 252 | 74 | 326 |
| 2025 9 | 239 | 78 | 317 |
| 2025 8 | 269 | 78 | 347 |
| 2025 7 | 230 | 57 | 287 |
| 2025 6 | 212 | 30 | 242 |
| 2025 5 | 257 | 53 | 310 |
| 2025 4 | 231 | 115 | 346 |
| 2025 3 | 209 | 59 | 268 |
| 2025 2 | 166 | 48 | 214 |
| 2025 1 | 73 | 29 | 102 |
| 2024 12 | 131 | 33 | 164 |
| 2024 11 | 141 | 26 | 167 |
| 2024 10 | 132 | 39 | 171 |
| 2024 9 | 139 | 25 | 164 |
| 2024 8 | 144 | 21 | 165 |
| 2024 7 | 118 | 35 | 153 |
| 2024 6 | 111 | 34 | 145 |
| 2024 5 | 116 | 24 | 140 |
| 2024 4 | 125 | 25 | 150 |
| 2024 3 | 138 | 21 | 159 |
| 2024 2 | 123 | 18 | 141 |
| 2024 1 | 119 | 28 | 147 |
| 2023 12 | 73 | 31 | 104 |
| 2023 11 | 140 | 18 | 158 |
| 2023 10 | 154 | 44 | 198 |
| 2023 9 | 110 | 14 | 124 |
| 2023 8 | 98 | 16 | 114 |
| 2023 7 | 139 | 24 | 163 |
| 2023 6 | 105 | 32 | 137 |
| 2023 5 | 145 | 24 | 169 |
| 2023 4 | 126 | 24 | 150 |
| 2023 3 | 86 | 22 | 108 |
| 2023 2 | 93 | 24 | 117 |
| 2023 1 | 83 | 50 | 133 |
| 2022 12 | 68 | 39 | 107 |
| 2022 11 | 47 | 41 | 88 |
| 2022 10 | 57 | 46 | 103 |
| 2022 9 | 70 | 50 | 120 |
| 2022 8 | 58 | 45 | 103 |
| 2022 7 | 37 | 27 | 64 |
| 2022 6 | 36 | 25 | 61 |
| 2022 5 | 34 | 46 | 80 |
| 2022 4 | 36 | 36 | 72 |
| 2022 3 | 39 | 49 | 88 |
| 2022 2 | 26 | 35 | 61 |
| 2022 1 | 33 | 39 | 72 |
| 2021 12 | 23 | 38 | 61 |
| 2021 11 | 18 | 37 | 55 |
| 2021 10 | 57 | 50 | 107 |
| 2021 9 | 20 | 42 | 62 |
| 2021 8 | 16 | 35 | 51 |
| 2021 7 | 12 | 31 | 43 |
| 2021 6 | 22 | 38 | 60 |
| 2021 5 | 22 | 47 | 69 |
| 2021 4 | 35 | 119 | 154 |
| 2021 3 | 19 | 39 | 58 |
| 2021 2 | 18 | 30 | 48 |
| 2021 1 | 20 | 34 | 54 |
| 2020 12 | 1 | 24 | 25 |
| 2020 11 | 0 | 20 | 20 |
| 2020 10 | 1 | 14 | 15 |
| 2020 9 | 0 | 17 | 17 |
| 2020 8 | 0 | 36 | 36 |
| 2020 7 | 0 | 3 | 3 |
| 2020 6 | 0 | 3 | 3 |
| 2020 5 | 0 | 10 | 10 |
| 2020 4 | 0 | 6 | 6 |
| 2020 3 | 0 | 5 | 5 |
| 2020 2 | 0 | 6 | 6 |
| 2020 1 | 0 | 1 | 1 |
| 2019 12 | 0 | 1 | 1 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 0 | 7 | 7 |
| 2019 9 | 0 | 7 | 7 |
| 2019 8 | 0 | 4 | 4 |
| 2019 7 | 0 | 7 | 7 |
| 2019 6 | 0 | 13 | 13 |
| 2019 5 | 0 | 46 | 46 |
| 2019 4 | 0 | 4 | 4 |
| 2018 8 | 0 | 1 | 1 |
| 2018 6 | 0 | 2 | 2 |
| 2018 5 | 0 | 1 | 1 |
| 2018 3 | 0 | 2 | 2 |
| 2018 2 | 4 | 10 | 14 |
| 2018 1 | 8 | 4 | 12 |
| 2017 12 | 6 | 4 | 10 |
| 2017 11 | 11 | 18 | 29 |
| 2017 10 | 17 | 13 | 30 |
| 2017 9 | 11 | 11 | 22 |
| 2017 8 | 18 | 20 | 38 |
| 2017 7 | 21 | 24 | 45 |
| 2017 6 | 10 | 16 | 26 |
| 2017 5 | 28 | 21 | 49 |
| 2017 4 | 19 | 52 | 71 |
| 2017 3 | 16 | 21 | 37 |
| 2017 2 | 16 | 13 | 29 |
| 2017 1 | 20 | 16 | 36 |
| 2016 12 | 22 | 16 | 38 |
| 2016 11 | 22 | 21 | 43 |
| 2016 10 | 34 | 15 | 49 |
| 2016 9 | 15 | 14 | 29 |
| 2016 8 | 26 | 9 | 35 |
| 2016 7 | 14 | 5 | 19 |
| 2016 6 | 25 | 26 | 51 |
| 2016 5 | 20 | 26 | 46 |
| 2016 4 | 17 | 33 | 50 |
| 2016 3 | 20 | 28 | 48 |
| 2016 2 | 25 | 30 | 55 |
| 2016 1 | 20 | 22 | 42 |
| 2015 10 | 0 | 1 | 1 |
| 2015 5 | 1 | 0 | 1 |
| 2015 4 | 0 | 8 | 8 |
| 2015 3 | 5 | 8 | 13 |
| 2015 2 | 5 | 5 | 10 |
Show all
